Guardant Health, Inc.GHNASDAQ
LOADING
|||
Alerts
Want to monitor GH?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor GHWant to monitor GH?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor GHGuardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients.